GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Thrombosis and Haemostasis, Georg Thieme Verlag KG, Vol. 102, No. 07 ( 2009), p. 97-110
    Abstract: In addition to haemostasis, platelets mediate inflammation and clearance of bacteria from the bloodstream. As with platelet-platelet interactions, platelet-bacteria interactions involve cytoskeletal rearrangements and release of granular content. Stimulation of the immune Toll-like receptor 2 (TLR2) on the platelet surface, activates phosphoinositide-3-kinase (PI3K) and causes platelet activation and plateletdependent thrombosis. It remains unknown if platelet activation by immune versus thrombotic pathways leads to the differential regulation of signal transduction, protein-protein interactions, and α-granule release, and the physiological relevance of these potential differences. We investigated these processes after immune versus thrombotic platelet stimulation. We examined selected signalling pathways and found that phosphorylation kinetics of Akt, ERK1/2 and p38 differed dramatically between agonists. Next, we investigated platelet protein-protein interactions by mass spectrometry (MS)-based proteomics specifically targeting cytosolic factor XIIIa (FXIIIa) because of its function as a cytoskeleton-crosslinking protein whose binding partners have limited characterisation. Four FXIIIa-binding proteins were identified, two of which are novel interactions: FXIIIa-focal adhesion kinase (FAK) and FXIIIa-gelsolin. The binding of FAK to FXIIIa was found to be altered differentially by immune versus thrombotic stimulation. Lastly, we studied the effect of thrombin versus Pam3CSK4 stimulation on α-granule release and observed differential release patterns for selected granule proteins and decreased fibrin clot formation compared with thrombin. The inhibition of PI3K caused a decrease in protein release after Pam3CSK4 -but not after thrombin-stimulation. In summary, stimulation of platelets by either thrombotic or immune receptors leads to markedly different signalling responses and granular protein release consistent with differential contribution to coagulation and thrombosis.
    Type of Medium: Online Resource
    ISSN: 0340-6245 , 2567-689X
    Language: English
    Publisher: Georg Thieme Verlag KG
    Publication Date: 2009
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Proteome Research, American Chemical Society (ACS), Vol. 16, No. 9 ( 2017-09-01), p. 3147-3157
    Type of Medium: Online Resource
    ISSN: 1535-3893 , 1535-3907
    Language: English
    Publisher: American Chemical Society (ACS)
    Publication Date: 2017
    detail.hit.zdb_id: 2065254-9
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: The FASEB Journal, Wiley, Vol. 33, No. 12 ( 2019-12), p. 14147-14158
    Abstract: Glutaredoxin‐1 (Glrx) is a small cytosolic enzyme that removes S ‐glutathionylation, glutathione adducts of protein cysteine residues, thus modulating redox signaling and gene transcription. Although Glrx up‐regulation prevented endothelial cell (EC) migration and global Glrx transgenic mice had impaired ischemic vascularization, the effects of cell‐specific Glrx overexpression remained unknown. Here, we examined the role of EC‐specific Glrx up‐regulation in distinct models of angiogenesis; namely, hind limb ischemia and tumor angiogenesis. EC‐specific Glrx transgenic (EC‐Glrx TG) overexpression in mice significantly impaired EC migration in Matrigel implants and hind limb revascularization after femoral artery ligation. Additionally, ECs migrated less into subcutaneously implanted B16F0 melanoma tumors as assessed by decreased staining of EC markers. Despite reduced angiogenesis, EC‐Glrx TG mice unexpectedly developed larger tumors compared with control mice. EC‐Glrx TG mice showed higher levels of VEGF‐A in the tumors, indicating hypoxia, which may stimulate tumor cells to form vascular channels without EC, referred to as vasculogenic mimicry. These data suggest that impaired ischemic vascularization does not necessarily associate with suppression of tumor growth, and that antiangiogenic therapies may be ineffective for melanoma tumors because of their ability to implement vasculogenic mimicry during hypoxia.—Yura, Y., Chong, B. S. H., Johnson, R. D., Watanabe, Y., Tsukahara, Y., Ferran, B., Murdoch, C. E., Behring, J. B., McComb, M. E., Costello, C. E., Janssen‐Heininger, Y. M. W., Cohen, R. A., Bachschmid, M. M., Matsui, R. Endothelial cell‐specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice. FASEB J. 33, 14147‐14158 (2019). www.fasebj.org
    Type of Medium: Online Resource
    ISSN: 0892-6638 , 1530-6860
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2019
    detail.hit.zdb_id: 1468876-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Journal of Proteome Research, American Chemical Society (ACS), Vol. 13, No. 9 ( 2014-09-05), p. 4074-4090
    Type of Medium: Online Resource
    ISSN: 1535-3893 , 1535-3907
    Language: English
    Publisher: American Chemical Society (ACS)
    Publication Date: 2014
    detail.hit.zdb_id: 2065254-9
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Analytical Chemistry, American Chemical Society (ACS), Vol. 74, No. 16 ( 2002-08-01), p. 4124-4132
    Type of Medium: Online Resource
    ISSN: 0003-2700 , 1520-6882
    Language: English
    Publisher: American Chemical Society (ACS)
    Publication Date: 2002
    detail.hit.zdb_id: 1483443-1
    detail.hit.zdb_id: 1508-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Wiley ; 2009
    In:  Rapid Communications in Mass Spectrometry Vol. 23, No. 24 ( 2009-12-30), p. 4019-4030
    In: Rapid Communications in Mass Spectrometry, Wiley, Vol. 23, No. 24 ( 2009-12-30), p. 4019-4030
    Abstract: The selective capture of target peptides poses a great challenge to modern chemists and biologists, especially when enriching them from proteome samples possessing extremes in concentration dynamic range and sequence diversity. While approaches based on traditional techniques such as biotin‐avidin pairing offer versatile tools to design strategies for selective enrichment, problems are still encountered due to sample loss or poor selectivity of enrichment. Here we show that the recently introduced fluorous chemistry approach has attractive properties as an alternative method for selective enrichment. Through appending a perfluorine group to the target peptide, it is possible to dramatically increase the peptide's hydrophobicity and thus enable facile separation of labeled from non‐labeled peptides. Use of reversed‐phase chromatography allowed for improved peptide recovery in comparison with results obtained using the formerly reported fluorous bonded phase methods. Furthermore, this approach also allowed for on‐line separation and identification of both labeled and unlabeled peptides in a single experiment. The net result is an increase in the confidence of protein identification by tandem mass spectrometry (MS 2 ) as all peptides and subsequent information are retained. Successful off‐line and on‐line enrichment of cysteine‐containing peptides was obtained, and high quality MS 2 spectra were obtained by tandem mass spectrometry due to the stability of the tag, allowing for facile identification via standard database searching. We believe that this strategy holds great promise for selective enrichment and identification of low abundance target proteins or peptides. Copyright © 2009 John Wiley & Sons, Ltd.
    Type of Medium: Online Resource
    ISSN: 0951-4198 , 1097-0231
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2009
    detail.hit.zdb_id: 2002158-6
    detail.hit.zdb_id: 58731-X
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Blood, American Society of Hematology, Vol. 122, No. 21 ( 2013-11-15), p. 3452-3452
    Abstract: Phenotype/genotype correlation can provide important insight into the pathophysiology of hemoglobin disorders and molecular mechanisms regulating globin gene expression. We present 2 unusual patients with β-globin gene cluster deletions of 44 and 589 kb. In the first case, the findings suggest that competition for LCR interaction among β-like globin gene promoters might not play a critical role in ε-globin gene silencing. The second case suggests that other factors in addition to deletion of the putative 3.5 kb silencer element 5' to the δ-globin gene are required for high HbF expression in adults. An African American newborn girl presented with marked hepatosplenomegaly, Coombs' negative hemolytic anemia, thrombocytopenia, and direct and indirect hyperbilirubinemia. She was transfused 3 times between birth and at 5 weeks of age. Since then, she maintained a mild anemia with microcytosis without need for further transfusions. At 3 years of age, her Hb was 10.1 g/dL, MCV 57 fL, reticulocyte count 2.0%, serum iron 65, TIBC 309, iron saturation 21%, total bilirubin 0.2. Hemoglobin analysis by HPLC revealed HbA 95.5%, HbA2 3.2%, HbF 1.3%. She did not have mutation in her α- and β-globin gene nucleotide sequences, or any of the common α-globin gene deletions. Multiplex ligation-dependent probe amplification (MLPA) of her β-globin gene cluster revealed that she had a deletion extending from 5' to the Gγ- to 3' to the β-globin genes. The deletion breakpoints were definitively identified by qPCR, followed by gap-PCR and nucleotide sequencing to be from chr11:5,244,999, 1,694 bp 3' to the β-globin gene, to chr11:5,288,826, 755 bp 3' to the ε-globin gene. This novel deletion of 43.8 kb in length removes the Gγ-, Aγ-, ψβ-, δ-, β-globin genes and the 3' β-enhancer, leaving the ε-globin gene and β-LCR intact. A gap-PCR diagnostic test was designed capable of definitive identification of this deletion. This group of (GγAγδβ)0-thalassemia deletions is known to cause neonatal hemolytic anemia of varying severity (Verhovsek et al, Pediatr Blood Cancer 2012;59:941-4) that evolves with age to assume a phenotype of simple β-thalassemia trait but with normal HbA2 level. In addition, mass spectrometry analysis of the hemolysate showed a normal expression profile for the α-globin chains, a decreased expression profile for the β-globin chains and no significant amount of the ε-globin chains. These findings do not support the hypothesis that competition for LCR interaction among β-like globin gene promoters plays an important role in ε-globin gene silencing in adults. A 65 year old man from Sudan presented with microcytic anemia, Hb 9.6 g/dL, MCV 70 fL, serum ferritin 130. Hemoglobin analysis by HPLC revealed HbA 91.9%, HbA2 2.7%, HbF 5.4%. MLPA revealed a deletion extending from the δ-globin gene to past the β-globin genes. This novel deletion of 588.6 kb in length (from chr11:4,670,164 to chr11:5,258,716) removes the δ- and β-globin genes. The 5' breakpoint of this deletion is 1.3 kb 5' to the 5' breakpoint of the French HPFH, and 652 bp 3' to the 5' breakpoint of HPFH1. Thus this deletion removes almost all of the 3.5 kb intergenic region 5' to the δ-globin gene thought to be important in γ-globin gene silencing in adults (Sankaran et al, N Engl J Med 2011;365:807-14). However, this patient had microcytosis and only moderately increased HbF as in (δβ)0-thalassemia rather than HPFH. These findings suggest that other factors in addition to deletion of the putative silencer, such as the nature of the sequences at the 3' breakpoint of the deletion or other structural features, can influence the occurrence of the HPFH phenotype associated with deletions in the β-globin gene cluster. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2013
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Blood, American Society of Hematology, Vol. 122, No. 21 ( 2013-11-15), p. 2233-2233
    Abstract: Pulmonary hypertension (PH), an independent risk factor for mortality in sickle cell disease (SCD), has epidemiologic links to systemic complications such as leg ulcers, priapism and renal disease suggestive of a diffuse vasculopathy. The pathogenesis of SCD related vasculopathy is unclear but altered redox biology is thought to be an important disease modifier. One potential mechanism by which this occurs is via plasma protein post-translational modifications (PTMs). Here we aim to identify a plasma protein and PTM signature profile reflective of PH and pulmonary vasculopathy related to SCD. By targeting both protein and PTM changes, we hoped to enhance the specificity of detecting biomarkers. To control for sex-related protein changes, we limited the present study to females. We obtained peripheral blood samples from 1) SCD patients with a normal echocardiogram (n=10); 2) SCD patients with PH diagnosed by right heart catheterization (n=6) or a tricuspid regurgitant jet velocity 〉 2.5 m/sec suggestive of pulmonary vasculopathy (n=4) (total n=10); 3) Age- and racially- matched HbAA volunteers (n=11). Plasma was depleted of high abundance proteins using accepted protocols. We performed differential proteomic analysis of plasma and abundant protein-depleted plasma, and differential analysis of PTMs on abundant plasma proteins. Plasma was subjected to trypsin digestion and the peptides were analyzed by differential label-free LCMS/MS. Peptide and protein identification was performed utilizing Proteome Discoverer (Thermo-Fisher) and Mascot (Matrix Science). Data analysis was conducted using the Trans-Proteomics-Pipeline (ISB), Scaffold (Proteome Software), Progenesis LCMS (Nonlinear Dynamics) and STRAP-PTM (in-house). LCMS/MS analysis of the entire plasma proteome revealed more than 2,500 changes in peptide expression between groups and almost 400 peptides which contained PTMs differentiating the SCD patients from the normal volunteers (ANOVA p 〈 0.05). Analyses indicated significant fold changes for a large group of known plasma protein markers associated with cardiovascular disease, redox biology and metabolism, and the inflammatory host response including alpha-2-HS glycoproteins, ceruloplasmin, apolipoprotein E, transthyretin, kininogen, carbonic anhydrase, angiotensinogen, and complement C4. We also observed changes in the PTMs of several plasma proteins including human albumin, particularly S-cysteinylation on Cys-34, and significant modifications by lipid peroxidation and glycation-end products, such as malonyldialdehyde, 4-hydroxynonenal, and hexose. Further refinement of the data to look only at the SCD samples demonstrated an increased frequency of oxidative PTMs on proteins and peptides from those with PH or an elevated TRV. Additionally, we identified 19 peptides which were distinct in the PH group compared with SCD patients with normal cardiopulmonary function. The corresponding proteins were identified as those important in redox biology, nitric oxide and nitrite signaling, and vasodilatation. This suggests that utilization of proteomics technologies may help to identify unique biomarkers reflective of disease progression and pathogenesis which may help to risk stratify patients and assess response to therapy. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2013
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Blood, American Society of Hematology, Vol. 122, No. 3 ( 2013-07-18), p. 376-385
    Abstract: This breakthrough involves the role of the aryl hydrocarbon receptor in the expansion and specification of hematopoietic progenitor cells. This work sets a precedent for the use of an in vitro platform for the clinically relevant production of blood products.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2013
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Blood, American Society of Hematology, Vol. 112, No. 11 ( 2008-11-16), p. 4814-4814
    Abstract: Background: Pulmonary hypertension (PH) in sickle cell anemia (SCA) is characterized by decreased nitric oxide bioavailability; which may, in part, be related to increased oxidative stress. It is possible that via protein post-translational modifications, oxidants are able to affect both protein structure and function. We hypothesized that, in patients with SCA and PH, oxidative post-translational modifications (PTMs) occur on plasma proteins and are important in disease pathogenesis. We previously reported the identification of one PTM, a malondialdehyde adduct on peptide 146–159 of albumin and sought to do a more extensive evaluation of this protein to determine the presence of other abnormalities. Methods: Plasma was obtained from subjects with: SCA and PH (n=5); SCA steady-state without PH (n=4); Pulmonary Arterial Hypertension (PAH) (n=4); no evidence of cardiopulmonary disease (n=4). Platelet-poor plasma was separated into albumin-enriched and albumin-depleted fractions. The albumin-enriched fraction was subjected to proteolytic digestion by trypsin and studied by matrix-assisted-laser desorption/ionization (MALDI) mass spectrometry (MS) and liquid chromatography (LC)-MS/MS tandem mass spectrometry. Proteomic analyses were performed on all samples and post-translational modifications characterized by MS/MS. Results: We have characterized several additional peptides of albumin from patients with PH of SCA that bear lipid peroxidation and glycation adducts. Our comprehensive LC-MS/MS results have allowed us to identify 4-hydroxynonenal (HNE), hexose (HEX) and malonyl adduction at numerous, distinct cysteine, histidine, lysine, and threonine albumin residues. Conclusion: Increased oxidant burden and altered redox biology is characteristic of PH in SCA. Plasma proteins, such as albumin, are a target for oxidants and changes in their structure may play a role in disease pathogenesis.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2008
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...